BioSpace News Archive

Drug Development

Azafaros Announces Enrollment of First Patient in Phase 2 RAINBOW Study Evaluating AZ-3102 in GM2 and NP-C Patients

Azafaros B.V. announced that the first patient has been enrolled into its Phase 2 RAINBOW study.

June 8, 2023
·
5 min read
BioMidwest

OBVIUS Robotics™ Announces Completion of Successful First-In-Human Cases

Obvius Robotics, Inc., a medical device company that has developed an innovative technology platform for performing percutaneous access, announced the successful completion of its first human cases.

June 8, 2023
·
2 min read
Business

Opthea Appoints Anshul Thakral as Non-Executive Director of the Board

Opthea Limited, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, is pleased to announce the appointment of Mr. Anshul Thakral as a Non-Executive Director of the Company’s Board of Directors.

June 8, 2023
·
4 min read
Genetown

Synlogic Reminds Stockholders of 2023 Annual General Meeting Details

Synlogic, Inc., the leading company advancing therapeutics based on synthetic biology, reminded stockholders that it will hold its 2023 Annual General Meeting of Stockholders on Thursday, June 15, 2023 at 8:00 a.m. EST.

June 8, 2023
·
4 min read
Protalix BioTherapeutics to Host In-Person KOL Breakfast following the Approval of Elfabrio® in both the United States and the European Union for Adults with Fabry Disease

Protalix BioTherapeutics, Inc. today announced it will host an in-person KOL breakfast in New York on Tuesday, June 27, 2023 at 8:00 a.m. Eastern Daylight Time (EDT), with presentations beginning at 8:30 a.m. EDT.

June 8, 2023
·
4 min read
Business

Pulmocide Announces Expansion of Management Team

Pulmocide Ltd. today announced the appointments of Matt Dallas as its Chief Financial Officer and Ashish Sagrolikar as its Chief Commercial Officer.

June 8, 2023
·
5 min read
Drug Development

LianBio Completes Enrollment in Pivotal Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis

LianBio today announced the completion of enrollment in the Phase 3 LIBRA clinical trial of TP-03 in Chinese patients with Demodex blepharitis.

June 8, 2023
·
6 min read
Business

Bristol Myers Squibb to Report Results for Second Quarter 2023 on July 27, 2023

Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2023 on Thursday, July 27, 2023.

June 8, 2023
·
1 min read
Business

KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA

Kazia Therapeutics Limited is pleased to announce that it is supporting the University of Sydney on a molecularly-guided phase II clinical study to examine paxalisib in adult patients with recurrent/progressive isocitrate dehydrogenase (IDH) mutant grade 2 and 3 glioma.

June 8, 2023
·
7 min read
Business

Aviko Radiopharmaceuticals and Neutron Therapeutics Form Strategic Partnership to Advance Boron Neutron Capture Therapy

Aviko Radiopharmaceuticals and Neutron Therapeutics today announced the formation of a strategic partnership to advance BNCT to treat cancer.

June 8, 2023
·
4 min read